We are live on ! Find out more
BC

Burleson & Co Portfolio holdings

AUM $401M
1-Year Est. Return 25.44%
This Fund
S&P 500
This Quarter Est. Return
-1.69%
1 Year Est. Return
-25.44%
3 Year Est. Return
+49.06%
5 Year Est. Return
+69.5%
10 Year Est. Return
AUM
$673M
AUM Growth
-$11.7M
Cap. Flow
+$5.66M
Cap. Flow %
0.84%
Top 10 Hldgs %
47.68%
Holding
429
New
47
Increased
87
Reduced
70
Closed
43

Sector Composition

Rank Sector Weight
1 Technology 30.09%
2 Miscellaneous 24.84%
3 Consumer Discretionary 20.44%
4 Communication Services 6.54%
5 Healthcare 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PG icon
26
Procter & Gamble
PG
$344B
$6.57M 0.98%
47,012
+2,521
+6% +$357K
SCHG icon
27
Schwab US Large-Cap Growth ETF
SCHG
$67.5B
$5.97M 0.89%
322,688
+84,600
+36% +$1.61M
BIV icon
28
Vanguard Intermediate-Term Bond ETF
BIV
$28.5B
$5.96M 0.89%
66,646
+8,130
+14% +$736K
QNCX icon
29
CALL
Quince Therapeutics
QNCX
$31.9M
$5.36M 0.8%
+1,198
New +$19.1M
RIDE
30
CALL
DELISTED
Lordstown Motors Corp. Class A Common Stock
RIDE
$4.79M 0.71%
+252,587
New +$26.2M
GOOGL icon
31
Alphabet (Google) Class A
GOOGL
$4.29T
$4.3M 0.64%
32,180
+160
+0.5% +$21.8K
LQD icon
32
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$28.2B
$4.3M 0.64%
32,302
+328
+1% +$44.3K
MCD icon
33
McDonald's
MCD
$177B
$4.13M 0.61%
17,110
+8
+0% +$1.91K
IEI icon
34
iShares 3-7 Year Treasury Bond ETF
IEI
$17.1B
$4.02M 0.6%
30,883
+260
+0.8% +$34.1K
META icon
35
Meta Platforms (Facebook)
META
$1.88T
$3.96M 0.59%
11,656
LLY icon
36
Eli Lilly
LLY
$1.04T
$3.91M 0.58%
16,913
ABBV icon
37
AbbVie
ABBV
$469B
$3.57M 0.53%
33,111
-1,249
-4% -$143K
VB icon
38
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
$3.21M 0.48%
14,661
+7,270
+98% +$1.62M
VWO icon
39
Vanguard FTSE Emerging Markets ETF
VWO
$129B
$2.99M 0.44%
59,747
+4,237
+8% +$219K
AMTI
40
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
$2.96M 0.44%
114,277
+8,000
+8% +$254K
JPM icon
41
JPMorgan Chase
JPM
$904B
$2.95M 0.44%
18,014
+16
+0.1% +$2.51K
T icon
42
AT&T
T
$172B
$2.93M 0.44%
143,804
-65,188
-31% -$1.37M
WFC icon
43
Wells Fargo
WFC
$251B
$2.79M 0.41%
60,146
-376
-0.6% -$17.4K
WBD icon
44
Warner Bros
WBD
$77.3B
$2.78M 0.41%
+109,604
New +$3.08M
VBK icon
45
Vanguard Morningstar Small-Cap Growth ETF
VBK
$23.3B
$2.67M 0.4%
9,524
-4,812
-34% -$1.38M
BMRC icon
46
Bank of Marin Bancorp
BMRC
$453M
$2.49M 0.37%
65,931
+4
+0% +$139
VO icon
47
Vanguard Morningstar Mid-Cap ETF
VO
$105B
$2.44M 0.36%
41,244
+1,744
+4% +$105K
JNJ icon
48
Johnson & Johnson
JNJ
$649B
$2.43M 0.36%
15,050
-387
-3% -$66K
VZ icon
49
Verizon
VZ
$193B
$2.42M 0.36%
44,737
-3,369
-7% -$186K
XLK icon
50
State Street Technology Select Sector SPDR ETF
XLK
$127B
$2.33M 0.35%
31,232
-714
-2% -$55.1K

Similar funds

Burleson & Co's Q3 2021 Portfolio in Review

As of Q3 2021, Burleson & Co held 429 positions worth $673M, down 1.7% from $685M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Burleson & Co's Q3 2021 filing shows 47 new, 87 increased, 70 reduced and 43 closed positions. Its largest new stake was Warner Bros: 109,604 shares worth $2.78M. The largest sale was Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri, an estimated $12.2M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Consumer Discretionary.

  • Burleson & Co's largest Q3 2021 buy was Warner Bros: 109,604 shares worth $2.78M.
  • Burleson & Co added most to Stem in Q3 2021, an estimated $11.8M increase.
  • Burleson & Co's biggest Q3 2021 reduction was Coinbase, cutting an estimated $7.29M.
  • Burleson & Co fully exited Stem, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise pri in Q3 2021, selling an estimated $12.2M.
  • Burleson & Co's ten largest holdings make up 48% of its $673M portfolio in Q3 2021.
  • Burleson & Co opened 47 new positions and closed 43 in Q3 2021.
  • Burleson & Co's portfolio value fell 1.7% quarter-over-quarter to $673M.

Based on Burleson & Co's 13F filing for Q3 2021, filed 2 Nov 2021.